Filter By Industry
Filter By Tag

Newsroom

Biochempeg Scientific Inc. Press releases

1 - 10 of 17 Press Releases

Oct 19, 2021
The coronavirus pandemic has made vaccines from Pfizer/BioNTech and Moderna and the mRNA technology that they use into household names.

Sep 26, 2021
Physician-scientists in the Cancer Center at Children's Hospital of Philadelphia (CHOP) have developed a preclinical, potent therapy attached to an antibody that targets a surface protein expressed in most childhood neuroblastomas, effectively killing...

Aug 17, 2021
The FDA amended the emergency use authorizations (EUAs) for both the Pfizer-BioNTech & the Moderna COVID-19 Vaccine to allow for the use of an additional dose in certain immunocompromised individuals.

Jul 26, 2021
Unlike common diseases such as colds and coughs, cancer is a more significant disease with a high mortality rate. Globally, cancer causes the second largest number of deaths after cardiovascular disease.

Jun 09, 2021
Monodisperse PEG products usually are organic compounds with a molecular weight of less than 1000. Monodispersed PEG linkers are pure compounds with a single molecular weight.

May 13, 2021
The Pfizer-BioNTech COVID-19 mRNA vaccine (Tozinameran or BNT162b2) is used to protect against COVID-19. This disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Apr 27, 2021
The FDA has granted accelerated approval to Sacituzumab Govitecan on April 13, 2021 for use in adult patients with locally advanced or metastatic urothelial cancer who have previously received platinum-containing chemotherapy and either a programmed...

Mar 24, 2021
Click chemistry has come into its own in a wide range of life science applications and opens up opportunities that lie between chemistry, biology and material science.

Jan 22, 2021
On April 22, the FDA approved sacituzumab govitecan for the treatment of adult patients with metastatic triple-negative breast cancer who have received at least two prior therapies for metastatic disease.

Dec 24, 2020
Ludwig-Maximilians-Universitaet (LMU) in Munich researchers have developed a novel type of nanoparticle that efficiently and selectively kills cancer cells, thus opening up new therapeutic options for the treatment of tumors.


Page: 1 2 Next
Biochempeg Scientific Inc. RSS Feed